Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) Sees Significant Decrease in Short Interest

Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) was the recipient of a large drop in short interest in September. As of September 30th, there was short interest totaling 38,370 shares, a drop of 39.1% from the September 15th total of 63,055 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 1 shares, the days-to-cover ratio is currently 38,370.0 days.

Recordati Industria Chimica E Farmaceutica Stock Performance

OTCMKTS RCDTF remained flat at $58.79 on Friday. The firm’s fifty day simple moving average is $58.17 and its 200 day simple moving average is $57.91. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.26 and a quick ratio of 0.86. The stock has a market cap of $12.13 billion, a PE ratio of 20.97 and a beta of 0.26. Recordati Industria Chimica E Farmaceutica has a 12-month low of $55.88 and a 12-month high of $60.00.

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.91 EPS for the quarter. Recordati Industria Chimica E Farmaceutica had a net margin of 18.38% and a return on equity of 33.73%. The company had revenue of $810.70 million during the quarter.

Recordati Industria Chimica E Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company focused on the research, development, manufacture and commercialization of medicines. Its activities are centered on specialty-care and rare-disease treatments, with products addressing areas such as endocrinology, oncology, urology, cardiology, gastroenterology and other specialized medical needs.

The company markets both proprietary and licensed medicines, serving patients through prescription products and therapies for uncommon or underserved conditions.